Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thiophene-2,5-disulfonic acid 2-amide-5-(4-methyl-benzylamide) is a synthetic small molecule compound with the molecular formula C12H14N2O4S3 and a molecular weight of approximately 346.45 g/mol. It is also known by the code name AL5917. This compound belongs to the class of organic compounds known as toluenes and features both sulfonamide and thiophene moieties[1][2]. Experimental data indicate that it acts as a potent inhibitor of carbonic anhydrase 2 (CA II), with reported binding affinity in the sub-nanomolar range (Kd = 0.46 nM)[2]. There are no approved indications or clinical trials for this compound; it remains an experimental agent primarily studied for its biochemical properties as a carbonic anhydrase inhibitor[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thiophene-2,5-disulfonic acid 2-amide-5-(4-methyl-benzylamide).